To explore whether the promoter region of SATB2 was hypermethylated in CRC tumor tissues, we first predicted the CpG island in the promoter region of SATB2 and designed MSP primers via MethPrimer (Supporting Information S1: Figure 1). The gene discussed is SATB2; the disease is neoplasm.